Last reviewed · How we verify
NCT04680013
Genetic Studies in Familial Dementia
trial in Dementia of Alzheimer Type in 4,884 participants. Completed in 29 October 2024.
29 October 2024
Quick facts
| Lead sponsor | University of Miami |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,884 |
| Start date | 1 June 2007 |
| Primary completion | 29 October 2024 |
| Estimated completion | 29 October 2024 |
| Sites | 1 location across United States |
Conditions studied
- Dementia of Alzheimer Type — all drugs for Dementia of Alzheimer Type →
- Alzheimer Disease, Late Onset — all drugs for Alzheimer Disease, Late Onset →
- Alzheimer Disease, Early Onset — all drugs for Alzheimer Disease, Early Onset →
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Sponsor
University of Miami
Who can join
18 and older, any sex, with Dementia of Alzheimer Type or Alzheimer Disease, Late Onset. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to identify genetic factors that contribute to or cause dementia (loss of memory) and related disorders across all ages and ethnic groups. This includes a number of neurological diseases such as early and late-onset Alzheimer disease, mild cognitive impairment, and other dementias.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04680013
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dementia of Alzheimer Type
Currently open trials in the same condition.
- NCT05336695 — Assess Fibrin in Brains With AD/ADRD · Phase 1, PHASE2 · recruiting
- NCT04240561 — Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia · NA · recruiting
- NCT04956549 — Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI) · NA · recruiting
- NCT05893524 — Uppsala-Dalarna Dementia and Gait Project · recruiting
Other University of Miami trials
Trials by the same sponsor.
- NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
- NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
- NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
- NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
- NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04680013 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Miami
- Last refreshed: 3 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04680013.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing